Skip to main content

Cancer Biomarkers

Promotes research to identify, develop, and validate biological markers for early cancer detection, risk prediction, and prevention. Supports development of collaborative databases and informatics systems, advancement of new technologies, and refinement of existing technologies.

On This Page

All Heading 2s will automatically be pulled in to this list.
Do not edit the content on this template.

Major Programs

Staff List

Grid View

Photo	Name, Email, Phone	Room	Group(s)/Office
	Evans Williams, Felicia, M.B.A. felicia.evanslong@nih.gov 240-276-5076	5E636	Program Analyst \| Cancer Biomarkers
	Fu, Sidney, M.D. sidney.fu@nih.gov 240-276-6669	5E134	Program Officer \| Cancer Biomarkers
	Hodges, Nicholas, Ph.D. nick.hodges@nih.gov 240-276-7844	5E616	Program Officer \| Cancer Biomarkers
	Kohaar, Indu, Ph.D., M.Phil., M.Sc. indu.kohaar@nih.gov 240-620-0875	5E612	Program Officer \| Cancer Biomarkers
	Krueger, Karl, Ph.D. [V] karl.krueger@nih.gov		Volunteer \| Cancer Biomarkers
	Marquez, Guillermo, Ph.D. guillermo.marquez@nih.gov 240-276-7035	5E132	Program Officer \| Cancer Biomarkers
	Orr, Susan susan.orr@nih.gov 240-276-5001	5E626	Program Support Assistant \| Cancer Biomarkers
	Patriotis, Christos, Ph.D., M.Sc. christos.patriotis@nih.gov 240-276-7134	5E614	Deputy Chief \| Cancer Biomarkers
	Petruzzelli, Angie angie.petruzzelli@nih.gov 240-276-5076	5E624	Program Support Assistant \| Cancer Biomarkers
	Srivastava, Sudhir, Ph.D., M.P.H. sudhir.srivastava@nih.gov 240-276-7028	5E136	Chief \| Cancer Biomarkers
	Villanueva, Juan Miguel juan.villanueva@nih.gov	5E630	Program Analyst \| Cancer Biomarkers
	Wang, Wendy, Ph.D., M.Sc. wendy.wang@nih.gov 240-276-7117	5E566	Program Officer \| Cancer Biomarkers
	Young, Matthew, Ph.D. matthew.young@nih.gov 240-276-5846	5E610	Program Officer \| Cancer Biomarkers

Grants

PI Name	PI Organization	Title Sort descending	Grant Number	Program Official
Lokshin, Anna E	University Of Pittsburgh At Pittsburgh United States	Development of Novel Ovarian Cancer Biomarkers for Early Detection Algorithms	5R01CA247220-05	Christos Patriotis, Ph.D., M.Sc.
Hitchins, Megan P	H. Lee Moffitt Cancer Ctr & Res Inst United States	Discovery and verification of methylated circulating tumor DNA markers for the detection of colorectal cancer in subjects under 50 years of age	7R01CA252042-05	Matthew Young, Ph.D.
Ibsen, Stuart Duncan	Oregon Health & Science University United States	Distinguishing Pancreatic Cancer from Benign Pancreatic Disease using Nanoparticle-based Biomarkers	5R37CA258787-05	Matthew Young, Ph.D.
Figueiredo, Jane C.	Cedars-Sinai Medical Center United States	Diversity and Determinants of the Immune-Inflammatory Response to SARS-CoV-2	3U54CA260591-02S4	Christos Patriotis, Ph.D., M.Sc.
Velculescu, Victor E.	Johns Hopkins University United States	DNA evaluation of fragments for early interception (DELFI) of Lung cancer	5U01CA271896-03	Guillermo Marquez, Ph.D.
Grimm, Lars J	Duke University United States	Dynamic imaging and tissue biomarker models to delineate indolent from aggressive breast calcifications	4R01CA271237-04	Guillermo Marquez, Ph.D.
Wang, Thomas D	University Of Michigan At Ann Arbor United States	Early detection of colorectal cancer in the traditional and serrated pathways	5R01CA249851-05	Guillermo Marquez, Ph.D.
Beretta, Laura	University Of Tx Md Anderson Can Ctr United States	Early Detection of Hepatocellular Carcinoma	5R01CA195524-09	Matthew Young, Ph.D.
Badve, Sunil S.	Emory University United States	Early prediction of lethal phenotypes in triple negative breast cancer using multiscale, multi-modality platforms	5R01CA281932-02	Wendy Wang, Ph.D., M.Sc.
Justilien, Verline	Mayo Clinic Jacksonville United States	ECT2 Isoform Switch in Pancreatic Cancer.	5R21CA296671-02	Matthew Young, Ph.D.
Wong, David T	University Of California Los Angeles United States	EFIRM Liquid Biopsy Research Laboratory: Early Lung Cancer Assessment	4U01CA233370-08	Nicholas Hodges, Ph.D.
Ahn, Eun Hyun	Johns Hopkins University United States	Engineered biomimetic collective cancer invasion models for screening chemotherapeutic agents	5R01CA279948-02	Guillermo Marquez, Ph.D.
Zarrinpar, Amir	University Of California, San Diego United States	Engineering Native E. coli to Detect, Report, and Treat Colorectal Cancer	5U01CA265719-05	Guillermo Marquez, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosomal biomarkers for the early detection of hepatocellular carcinoma	5R01CA271443-03	Matthew Young, Ph.D.
Goel, Ajay	Beckman Research Institute/City Of Hope United States	Exosome-based microRNA biomarkers for Non-invasive and Early Detection of Pancreatic Cancer	3U01CA214254-08S2	Matthew Young, Ph.D.